Wayne Winegarden

Commentary

The Regulatory Threat From Payment Do-Overs And Un-Economical Reimbursements

The Centers for Medicare & Medicaid Services issued an update to the home health payment system on June 22nd. This proposed rule, rife with legalese and sheer complexity, should be held up as Exhibit A for why socialized healthcare schemes such as Medicare for All will never work.   The proposal’s obsessions with “aggregate …

Blog

‘Housing First’ puts lofty goals about real-world results

Proponents of housing first claim that housing is a basic human right, and a permanent and stable home is the best platform from which to help people overcome the challenges that led to their homelessness, including the problems of mental illness and addiction.   As a result of this premise, …

Commentary

Reducing Access To Home Healthcare Services Will Raise Costs And Worsen Outcomes

The Centers for Medicare and Medicaid Services (CMS) recent decision on home healthcare services, if implemented, will increase overall healthcare expenditures and decrease the quality of services received by patients. CMS’ overarching goal is praiseworthy – the agency is trying to maintain budget neutrality while changing its payment system rates. …

Blog

Replacing White Bagging Mandates With Market Competition Will Improve Patient Outcome

Pharmacy benefit managers (PBMs) deploy numerous anticompetitive actions, which have not gone unnoticed. The Federal Trade Commission (FTC) has launched an inquiry to examine whether PBMs have adverse impacts “on the access and affordability of prescription drugs.” The government’s probe is welcome news. But there are many detrimental PBM practices that are …

Featured

NEW BRIEF: Biosimilars Save Patients Over $11 Billion Annually, Fixing Broken System Would Help Patients Save More

SACRAMENTO – Biosimilars competition saves patients and the health care system over $11 billion annually and could generate even more savings if the broken drug pricing system were reformed, finds a new issue brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. …

Business & Economics

The High Cost Of The Inflation Reduction Act

The right policy mix to address our current economic malaise is tighter monetary policy and pro-growth tax and regulatory policies. While the Federal Reserve is on the right track for monetary policy, the newly titled Inflation Reduction Act is completely wrongheaded. The tax provisions – such as imposing a minimum corporate tax …

California

Wayne Winegarden Talks California’s Project Homekey on Andy Caldwell Show

PRI’s Wayne Winegarden discusses California’s Project Homekey and his new study from Kerry Jackson and himself, “Project Homekey Provides No Way Home for California’s Homeless,” on the Andy Caldwell Show.

Business & Economics

Proxy Advisory Firms And The ESG Risk

Warren Buffett presciently noted that “only when the tide goes out do you discover who’s been swimming naked.” The Dow, S&P 500, and Nasdaq are all now in bear market territory, so the tide has undoubtedly receded. And true to Mr. Buffett’s wisdom, the unsustainability of many fashionable investment trends …

Blog

Drug Price Controls Are Not the Solution to Another Bad Inflation Report

The July 13th report on consumer price inflation (CPI-U) confirmed what we all already knew – prices have become unaffordable. Consumer price inflation rose 9.1 percent over the last year, which is the fastest inflation rate in 40+ years. The impetus for this current bout of inflation is not mysterious. …

Commentary

California’s climate lawsuits threaten to raise energy prices and harm consumers

The recent Supreme Court ruling in West Virginia v. EPA reinforced the commonsense notion that it is the responsibility of our elected representatives, not the courts, to establish our nation’s global climate change policies. If only the states and localities suing the global energy companies, many of which are here …

Commentary

The Regulatory Threat From Payment Do-Overs And Un-Economical Reimbursements

The Centers for Medicare & Medicaid Services issued an update to the home health payment system on June 22nd. This proposed rule, rife with legalese and sheer complexity, should be held up as Exhibit A for why socialized healthcare schemes such as Medicare for All will never work.   The proposal’s obsessions with “aggregate …

Blog

‘Housing First’ puts lofty goals about real-world results

Proponents of housing first claim that housing is a basic human right, and a permanent and stable home is the best platform from which to help people overcome the challenges that led to their homelessness, including the problems of mental illness and addiction.   As a result of this premise, …

Commentary

Reducing Access To Home Healthcare Services Will Raise Costs And Worsen Outcomes

The Centers for Medicare and Medicaid Services (CMS) recent decision on home healthcare services, if implemented, will increase overall healthcare expenditures and decrease the quality of services received by patients. CMS’ overarching goal is praiseworthy – the agency is trying to maintain budget neutrality while changing its payment system rates. …

Blog

Replacing White Bagging Mandates With Market Competition Will Improve Patient Outcome

Pharmacy benefit managers (PBMs) deploy numerous anticompetitive actions, which have not gone unnoticed. The Federal Trade Commission (FTC) has launched an inquiry to examine whether PBMs have adverse impacts “on the access and affordability of prescription drugs.” The government’s probe is welcome news. But there are many detrimental PBM practices that are …

Featured

NEW BRIEF: Biosimilars Save Patients Over $11 Billion Annually, Fixing Broken System Would Help Patients Save More

SACRAMENTO – Biosimilars competition saves patients and the health care system over $11 billion annually and could generate even more savings if the broken drug pricing system were reformed, finds a new issue brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. …

Business & Economics

The High Cost Of The Inflation Reduction Act

The right policy mix to address our current economic malaise is tighter monetary policy and pro-growth tax and regulatory policies. While the Federal Reserve is on the right track for monetary policy, the newly titled Inflation Reduction Act is completely wrongheaded. The tax provisions – such as imposing a minimum corporate tax …

California

Wayne Winegarden Talks California’s Project Homekey on Andy Caldwell Show

PRI’s Wayne Winegarden discusses California’s Project Homekey and his new study from Kerry Jackson and himself, “Project Homekey Provides No Way Home for California’s Homeless,” on the Andy Caldwell Show.

Business & Economics

Proxy Advisory Firms And The ESG Risk

Warren Buffett presciently noted that “only when the tide goes out do you discover who’s been swimming naked.” The Dow, S&P 500, and Nasdaq are all now in bear market territory, so the tide has undoubtedly receded. And true to Mr. Buffett’s wisdom, the unsustainability of many fashionable investment trends …

Blog

Drug Price Controls Are Not the Solution to Another Bad Inflation Report

The July 13th report on consumer price inflation (CPI-U) confirmed what we all already knew – prices have become unaffordable. Consumer price inflation rose 9.1 percent over the last year, which is the fastest inflation rate in 40+ years. The impetus for this current bout of inflation is not mysterious. …

Commentary

California’s climate lawsuits threaten to raise energy prices and harm consumers

The recent Supreme Court ruling in West Virginia v. EPA reinforced the commonsense notion that it is the responsibility of our elected representatives, not the courts, to establish our nation’s global climate change policies. If only the states and localities suing the global energy companies, many of which are here …

Scroll to Top